— Know what they know.
Not Investment Advice
Also trades as: NZYM-B.CO (CPH) · $vol 39M · NSIS-B.CO (CPH) · $vol 36M · NVZMY (OTC) · $vol 2M

NVZMF OTC

Novozymes A/S
1W: -3.7% 1M: -8.4% 3M: +1.7% YTD: +5.2% 1Y: +8.0% 3Y: +66.7% 5Y: -4.4%
$65.11
+0.00 (+0.00%)
 
OTC · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 46 · $30.4B mcap · 345M float · 0.0004% daily turnover · Short 34% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$30.4B
52W Range52.1-72.98
Volume500
Avg Volume1,227
Beta0.62
Dividend$1.02
Analyst Ratings
0 Buy 1 Hold 1 Sell
Consensus Hold
Company Info
CEOEster Baiget
Employees11,641
SectorBasic Materials
IndustryChemicals - Specialty
IPO Date2010-10-15
Biologiens Vej 2
Lyngby, ND 2800
DK
45 44 46 00 00
About Novozymes A/S

Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications. In household care, its products enhance laundry, dishwashing, and professional cleaning. For agriculture, Novozymes supports crop production with bioyield and biocontrol technologies, alongside animal health and nutrition solutions. It also contributes to industrial processing, providing solutions for grain and technical processes, as well as bioenergy applications encompassing liquefaction, saccharification, fermentation, and the conversion of fiber and biomass. Other significant areas of focus include textile treatments (such as biopreparation, biopolishing, and denim finishing), pulp and paper production (enhancing fiber modification, bleach boosting, and deinking), and leather processing (from soaking and bating to unhairing and degreasing). Furthermore, its expertise extends to water and waste management with bioaugmentation, biogas, and sludge control technologies. Additionally, Novozymes plays a role in pharmaceuticals, offering lipases and proteases for biocatalysis and rTrypsin for cell culture, in addition to broader human health and protein-related solutions.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms